NMS GROUP ONCOLOGY FORWARD
Live / Registered — Registered (as of 31 Jan 2023)
What this means for you
Registered since 31 Jan 2023. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 79323839
- Registration number
- 6966082
- Mark type
- Slogan / phrase
- Filed
- 09 Jul 2021
- Published for opposition
- 15 Nov 2022
- Registered
- 31 Jan 2023
- Attorney of record
- Jeffrey B. Sladkus, Esq.
Goods and services
- Class 042 — Scientific and technological services: Scientific, technological, analysis and research services, namely, research and development in the field of medicine, testing in the field of pharmaceuticals and gene-based drugs and therapies; biological research in the field of medicine, testing in the field of pharmaceuticals and gene-based drugs and therapies; chemical research in the field of medicine, testing in the field of pharmaceuticals and gene-based drugs and therapies; clinical trials in the field of medicine, testing in the field of pharmaceuticals and gene-based drugs and therapies; quality control in the field of medicine, testing in the field of pharmaceuticals and gene-based drugs and therapies; scientific laboratory services
Owner
- NMS GROUP S.P.A., IT
- NMS GROUP S.P.A., IT
- NMS GROUP S.P.A., IT
Prosecution history
- 15 Nov 2024 — NEW REPRESENTATIVE AT IB RECEIVED
- 23 May 2023 — FINAL DECISION TRANSACTION PROCESSED BY IB
- 04 May 2023 — FINAL DISPOSITION NOTICE SENT TO IB
- 04 May 2023 — FINAL DISPOSITION PROCESSED
- 30 Apr 2023 — FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
- 31 Jan 2023 — NOTICE OF REGISTRATION CONFIRMATION EMAILED
- 31 Jan 2023 — REGISTERED-PRINCIPAL REGISTER
- 15 Nov 2022 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 15 Nov 2022 — PUBLISHED FOR OPPOSITION
- 26 Oct 2022 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 04 Oct 2022 — WITHDRAWN FROM PUB - OG REVIEW QUERY
- 20 Sept 2022 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 17 Sept 2022 — TEAS/EMAIL CORRESPONDENCE ENTERED
- 16 Sept 2022 — CORRESPONDENCE RECEIVED IN LAW OFFICE
- 16 Sept 2022 — TEAS RESPONSE TO OFFICE ACTION RECEIVED